Cholangitis caused by Streptococcus gordonii: A case report and review of the literature

Q3 Medicine

Clinical Microbiology Newsletter Pub Date : 2025-06-18 DOI:10.1016/j.clinmicnews.2025.06.007

Kaoutar Jamal , Said Ezrari , Abderrazak Saddari , Sabah Mokhtari , Zahi Ismaili , Elmostapha Benaissa , Yassine Ben Lahlou , Mostafa Elouennass , Adil Maleb

{"title":"Cholangitis caused by Streptococcus gordonii: A case report and review of the literature","authors":"Kaoutar Jamal , Said Ezrari , Abderrazak Saddari , Sabah Mokhtari , Zahi Ismaili , Elmostapha Benaissa , Yassine Ben Lahlou , Mostafa Elouennass , Adil Maleb","doi":"10.1016/j.clinmicnews.2025.06.007","DOIUrl":null,"url":null,"abstract":"<div><div><em>Streptococcus gordonii</em> is a commensal bacterium rarely described in human infections. Herein, we describe a case of cholangitis due to <em>Streptococcus gordonii</em>. A 62-year-old woman, known to have had cholelithiasis, with history of gastroesophageal reflux and a brother who died of nasopharyngeal carcinoma, was admitted due to abdominal pain, fever, and jaundice. Abdominal computed tomography showed moderate dilation of the common and intrahepatic bile duct upstream of stones the distal ampullary portion, and cholelithiasis. The patient underwent endoscopic retrograde cholangiopancreatography and intraoperative sampling of bile fluid. The patient received empiric antibiotic therapy based on parenteral ceftriaxone and metronidazole. The microbiological analysis revealed the exclusive presence of <em>Streptococcus gordonii</em>. The initial treatment was maintained for 5 days and then replaced by oral amoxicillin-clavulanate and metronidazole. The clinical evolution was favorable. We present here a case of cholangitis caused by <em>Streptococcus gordonii</em> and a literature review.</div></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"52 ","pages":"Pages 24-30"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196439925000303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Streptococcus gordonii is a commensal bacterium rarely described in human infections. Herein, we describe a case of cholangitis due to Streptococcus gordonii. A 62-year-old woman, known to have had cholelithiasis, with history of gastroesophageal reflux and a brother who died of nasopharyngeal carcinoma, was admitted due to abdominal pain, fever, and jaundice. Abdominal computed tomography showed moderate dilation of the common and intrahepatic bile duct upstream of stones the distal ampullary portion, and cholelithiasis. The patient underwent endoscopic retrograde cholangiopancreatography and intraoperative sampling of bile fluid. The patient received empiric antibiotic therapy based on parenteral ceftriaxone and metronidazole. The microbiological analysis revealed the exclusive presence of Streptococcus gordonii. The initial treatment was maintained for 5 days and then replaced by oral amoxicillin-clavulanate and metronidazole. The clinical evolution was favorable. We present here a case of cholangitis caused by Streptococcus gordonii and a literature review.

查看原文本刊更多论文

戈多氏链球菌所致胆管炎1例报告及文献复习

戈多氏链球菌是一种很少在人类感染中描述的共生细菌。在此，我们描述一个病例胆管炎由于戈多氏链球菌。一名62岁女性，已知有胆石症，有胃食管反流病史，其兄弟死于鼻咽癌，因腹痛、发热和黄疸入院。腹部计算机断层扫描显示胆总管和肝内胆管在远端壶腹部分结石上游有中度扩张，胆石症。患者行内窥镜逆行胆管造影和术中胆液取样。患者接受以头孢曲松和甲硝唑为基础的经验性抗生素治疗。微生物学分析显示只存在戈登链球菌。初始治疗维持5 d，然后口服阿莫西林-克拉维酸和甲硝唑。临床进展良好。我们报告一例哥氏链球菌引起的胆管炎并作文献复习。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Microbiology Newsletter Medicine-Infectious Diseases

CiteScore

2.20

自引率

0.00%

发文量

审稿时长

53 days

期刊介绍： Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a “benchmark” for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones.